|
Patents and Trademarks, Net (Additional Information) (Detail) (USD $)
|
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Finite-Lived Intangible Assets [Line Items] | ||
| Amortization | $ 54,979 | $ 59,396 |
| Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months | 50,058 | |
| Impairment of Patents and Trademarks | 73,423 | 64,703 |
|
Abandoned Patents and Trademarks
|
||
| Finite-Lived Intangible Assets [Line Items] | ||
| Impairment of Patents and Trademarks | 73,423 | 64,703 |
| Amortization of Intangible Assets | 98,798 | 171,868 |
| Asset Impairment Cost | $ 25,375 | $ 107,165 |
| X | ||||||||||
|
- Definition
The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of amortization expense expected to be recognized during the next fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Asset Impairment Cost During Period No definition available.
|